Correlation Between Bristol-Myers Squibb and Amrica Mvil,

Can any of the company-specific risk be diversified away by investing in both Bristol-Myers Squibb and Amrica Mvil, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol-Myers Squibb and Amrica Mvil, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bristol Myers Squibb and Amrica Mvil, SAB, you can compare the effects of market volatilities on Bristol-Myers Squibb and Amrica Mvil, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol-Myers Squibb with a short position of Amrica Mvil,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol-Myers Squibb and Amrica Mvil,.

Diversification Opportunities for Bristol-Myers Squibb and Amrica Mvil,

-0.32

Correlation Coefficient

Bristol-Myers Squibb  Amrica Mvil,

Very good diversification

The 3 months correlation between Bristol-Myers and Amrica is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Amrica Mvil, SAB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amrica Mvil, SAB and Bristol-Myers Squibb is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Amrica Mvil,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amrica Mvil, SAB has no effect on the direction of Bristol-Myers Squibb i.e., Bristol-Myers Squibb and Amrica Mvil, go up and down completely randomly.

Pair Corralation between Bristol-Myers Squibb and Amrica Mvil,

Assuming the 90 days horizon Bristol Myers Squibb is expected to under-perform the Amrica Mvil,. But the pink sheet apears to be less risky and, when comparing its historical volatility, Bristol Myers Squibb is 1.2 times less risky than Amrica Mvil,. The pink sheet trades about -0.06 of its potential returns per unit of risk. The Amrica Mvil, SAB is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  70.00  in Amrica Mvil, SAB on November 20, 2024 and sell it today you would earn a total of  3.00  from holding Amrica Mvil, SAB or generate 4.29% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	27.12%
Values	Daily Returns

Bristol Myers Squibb  vs.  Amrica Mvil, SAB

Bristol Myers Squibb

Risk-Adjusted Performance

OK

Over the last 90 days Bristol Myers Squibb has generated negative risk-adjusted returns adding no value to investors with long positions. Even with fragile performance in the last few months, the Stock's primary indicators remain relatively invariable which may send shares a bit higher in March 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Amrica Mvil, SAB

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Amrica Mvil, SAB are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, Amrica Mvil, reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Bristol-Myers Squibb and Amrica Mvil,

The main advantage of trading using opposite Bristol-Myers Squibb and Amrica Mvil, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol-Myers Squibb position performs unexpectedly, Amrica Mvil, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amrica Mvil, will offset losses from the drop in Amrica Mvil,'s long position.

The idea behind Bristol Myers Squibb and Amrica Mvil, SAB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.